Wednesday, February 26, 2020
Home Medical Cannabis Partners Discover the natural alternative to pharmaceutical medicine with cannabis ingredients

Discover the natural alternative to pharmaceutical medicine with cannabis ingredients

LeafCann is a vertically integrated biotech company specialising in the production and manufacture of high quality, pharmaceutical grade cannabis ingredients and medicines.

As a licenced manufacturer of medicinal cannabis, LeafCann’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production and GMP manufacturing with cannabis ingredients. Through its subsidiary, Alchemy Bioservices, the world’s first Registered Training Organisation dedicated to the training, LeafCann supports the professionalisation and management of the emerging medicinal cannabis workforce.

The dynamic world of LeafCann

LeafCann is now building a robust and agile medicinal cannabis supply chain, forging export agreements and working towards ensuring patients have access to precision cannabis medicines made from the highest quality ingredients at affordable prices.

LeafCann’s vertically-integrated GMP methodology extends from propagation through controlled cultivation and into manufacture. LeafCann Manufacturing will use Supercritical CO2 (SCCO2) extraction to produce GMP grade medicinal cannabis whole plant extracts, isolates and Active Pharmaceutical Ingredients (APIs), and a limited range of white-label and branded finished products for domestic supply and export.

Creating a specialised medicinal cannabis organisation

LeafCann has taken the initiative to create a specialised medicinal cannabis Registered Training Organisation, Alchemy Bioservices, which is focused on facilitating education and certification for production, with a two pronged focus to upskill the global workforce and ensure professional medical staff such as doctors and nurses understand why, how and when to utilise Medicinal Cannabis as part of the treatment regime for patients.

Supported by an experienced and capable team, LeafCann is looking forward to being instrumental in working with the industry and all governments to ensure the future of medicinal cannabis reaches its full potential.

If you are interested in becoming involved with the Leafcann Group, contact them at

  • Behavioural and Psychological Symptoms of Dementia (BPSD), Crohn’s Disease, Parkinson’s Disease, Side effects of Menopause, Tourette’s Syndrome, Fibromyalgia and other orphan conditions
  • Person centred precision medicine
  • Building robust and agile supply chains
  • Super critical CO2 extraction processes
  • Developing training and guidance material to ensure a sustainable medicinal cannabis workforce

Article published In Health Europa quarterly, issue 10
Article published in Medical Cannabis Networks-Issue 1
Embedded booklet published in Medical Cannabis Networks-Issue 1

Pin It on Pinterest